Ingredalia has won a FoodTech Emprende Award in Barcelona. The Navarra startup received the prize for its bioactive ...

The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.

A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...

A patient in Germany has been successfully treated with a drug based on CRISPR gene-editing technology for the first time ...

A new analysis tracking three decades of public discussion about GM finds economic arguments have increasingly crowded out cultural and ethical questions.

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $54, representing a -5.82% change from its previous ...

Company to evaluate strategic alternatives to maximize stockholder value ---- Caribou plans to discontinue vispa-cel and CB-011 allogeneic ...

Clarke famously wrote, "Any sufficiently advanced technology is indistinguishable from magic." Kraig's approach gives that observation a wonderfully small, many-legged illustration. On September 29, ...